Literature DB >> 14841260

Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions.

B ALEXANDER, R GOLDSTEIN, G LANDWEHR, C D COOK.   

Abstract

Entities:  

Keywords:  BLOOD COAGULATION; HEMORRHAGIC DIATHESIS

Mesh：

Year:  1951        PMID： 14841260      PMCID： PMC436294          DOI： 10.1172/JCI102477

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  8 in total

1.  HUMAN PROTHROMBIN: QUANTITATIVE STUDIES ON THE PLASMA LABILE FACTOR AND THE RESTORATIVE EFFECTS OF NORMAL, HYPOFI-BRINOGENEMIC, AND HEMOPHILIC PLASMA ON THE PROTHROMBIN OF STORED PLASMA.

Authors:  B Alexander; A De Vries; E Addelson
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

2.  A Prothrombin Conversion Accelerator in Serum.

Authors:  B Alexander; A de Vries; R Goldstein; G Landwehr
Journal:  Science       Date:  1949-05-27       Impact factor: 47.728

3.  Evolution of a prothrombin conversion accelerator in stored human plasma and prothrombin fractions.

Authors:  B ALEXANDER; G LANDWEHR
Journal:  Am J Physiol       Date:  1949-11

4.  Hypoprothrombinemia; studies of a case of the idiopathic type and the effect of serum administration.

Authors:  C L CROCKETT; D SHOTTON
Journal:  Blood       Date:  1949-12       Impact factor: 22.113

5.  The prothrombin conversion accelerator of serum (SPCA): its partial purification and its properties compared with serum AC-globulin.

Authors:  B ALEXANDER; R GOLDSTEIN; G LANDWEHR
Journal:  J Clin Invest       Date:  1950-07       Impact factor: 14.808

6.  Coagulation defect in hepatic disorders: deficiency of prothrombin-conversion accessory substances.

Authors:  B ALEXANDER; R GOLDSTEIN
Journal:  J Clin Invest       Date:  1950-06       Impact factor: 14.808

7.  Congenital hypoprothrombinemia; a case study with particular reference to the role of non-prothrombin factors in the conversion of prothrombin.

Authors:  G LANDWEHR; H LANG; B ALEXANDER
Journal:  Am J Med       Date:  1950-02       Impact factor: 4.965

8.  Prothrombin consumption, serum prothrombic activity and prothrombin conversion accelerator in hemophilia and thrombocytopenia.

Authors:  B ALEXANDER; G LANDWEHR
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808
  8 in total
  40 in total

1.  The Laboratory of Coagulation A review of present laboratory techniques.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998       Impact factor: 2.300

2.  Surgical management in hemophilia and the hemophilioid diseases.

Authors:  I W BROWN; W W SMITH; R M HOWSE
Journal:  Ann Surg       Date:  1959-05       Impact factor: 12.969

3.  The hereditary haemorrhagic diseases: their classification and diagnosis.

Authors:  A J QUICK
Journal:  Br Med J       Date:  1959-04-25

4.  Disappearance rate of concentrated proconvertin extracts in congenital and acquired hypoproconvertinemia.

Authors:  M HOAG; P M AGGELER; A H FOWELL
Journal:  J Clin Invest       Date:  1960-03       Impact factor: 14.808

5.  The effect of hepatic lobectomy on some blood clotting factors and on fibrinolysis.

Authors:  M B ZUCKER; M SIEGEL; E E CLIFFTON; J W BELLVILLE; W S HOWLAND; C E GROSSI
Journal:  Ann Surg       Date:  1957-11       Impact factor: 12.969

6.  [Congenital familial hypoproconverteinemia].

Authors:  U M SERAFINI; F PERICOLI
Journal:  Blut       Date:  1957-05

7.  Stuart clotting defect. II. Genetic aspects of a new hemorrhagic state.

Authors:  J B GRAHAM; E M BARROW; C HOUGIE
Journal:  J Clin Invest       Date:  1957-03       Impact factor: 14.808

8.  Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency.

Authors:  C HOUGIE; E M BARROW; J B GRAHAM
Journal:  J Clin Invest       Date:  1957-03       Impact factor: 14.808

9.  Familial haemophilia and factor VII deficiency.

Authors:  M CONSTANDOULAKIS
Journal:  J Clin Pathol       Date:  1958-09       Impact factor: 3.411

10.  Application of continuous flow electrophoresis to the study of the blood coagulation proteins and the fibrinolytic enzyme system. I. Normal human materials.

Authors:  J H LEWIS; D WALTERS; P DIDISHEIM; W R MERCHANT
Journal:  J Clin Invest       Date:  1958-09       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.